Brendan Teehan - Net Worth and Insider Trading

Brendan Teehan Net Worth

The estimated net worth of Brendan Teehan is at least $1 Million dollars as of 2025-01-13. Brendan Teehan is the EVP, COO, HEAD OF COMMERCIAL of ACADIA Pharmaceuticals Inc and owns about 62,105 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $1 Million. Details can be seen in Brendan Teehan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brendan Teehan has not made any transactions after 2024-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Brendan Teehan

To

Brendan Teehan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brendan Teehan owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .

Click here to see the complete history of Brendan Teehan’s form 4 insider trades.

Insider Ownership Summary of Brendan Teehan

Ticker Comapny Transaction Date Type of Owner
ACAD ACADIA Pharmaceuticals Inc 2024-11-19 EVP & COO & Head of Commercial

Brendan Teehan Latest Holdings Summary

Brendan Teehan currently owns a total of 1 stock. Brendan Teehan owns 62,105 shares of ACADIA Pharmaceuticals Inc (ACAD) as of November 19, 2024, with a value of $1 Million.

Latest Holdings of Brendan Teehan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACAD ACADIA Pharmaceuticals Inc 2024-11-19 62,105 17.26 1,071,932

Holding Weightings of Brendan Teehan


Brendan Teehan Form 4 Trading Tracker

According to the SEC Form 4 filings, Brendan Teehan has made a total of 16 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 10,329 shares on November 19, 2024, which brought Brendan Teehan around $173,630.

Insider Trading History of Brendan Teehan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brendan Teehan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brendan Teehan Ownership Network

Ownership Network List of Brendan Teehan

No Data

Ownership Network Relation of Brendan Teehan

Insider Network Chart

Brendan Teehan Owned Company Details

What does ACADIA Pharmaceuticals Inc do?

Who are the key executives at ACADIA Pharmaceuticals Inc?

Brendan Teehan is the EVP & COO & Head of Commercial of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include Chief Financial Officer Mark C. Schneyer , Principal Accounting Officer James Kihara , and director & PRESIDENT AND CEO Stephen Davis .

ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary

Over the past 18 months, Brendan Teehan made 8 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 37,363. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 48,500 shares made by Mark C. Schneyer , a net sale of 248,334 shares made by Stephen Davis , and a net sale of 13,648 shares made by James Kihara .

In summary, during the past 3 months, insiders sold 24,661 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 24,661 shares. During the past 18 months, 364,804 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 364,804 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ACADIA Pharmaceuticals Inc Insider Transactions

No Available Data

Brendan Teehan Mailing Address

Above is the net worth, insider trading, and ownership report for Brendan Teehan. You might contact Brendan Teehan via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.